您当前所在位置: 首页 > 学者

黄灿华

  • 29浏览

  • 0点赞

  • 0收藏

  • 0分享

  • 79下载

  • 0评论

  • 引用

期刊论文

Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines

黄灿华Jun Shen ac Canhua Huang b Lu Jiang a Feng Gao a Zhi Wanga Yuanyuan Zhang a Jingping Bai a Hongmei Zhou a Qianming Chen a*

biochemical pharma cology73(2007)1901-1909,-0001,():

URL:

摘要/描述

Both the resistance of tumor cells to cisplatin and dose-related toxicity remain two of the most important problems in the chemotherapy of clinical oral squamous cell carcinoma (OSCC). Researchers have been seeking a combinative treatment regimen to improve the effect of chemotherapy. As potent new anti-cancer drugs, histone deacetylase inhibitors (HDACIS) have been reported to be associated with chromatin modification and display synergistic activities with some traditional chemotherapeutic agents. In this study, we evaluated the potential combinative effect of low dose cisplatin and suberoylanilide hydroxamic acid (SAHA, one of the most potent HDACIS) in OSCC cell lines. Cell viability and apoptotic assay were examined. Compared with either cisplatin (4mg/ml) or SAHA (2mM) treated alone, co-administration of both drugs synergistically induces cytotoxicity and apoptosis in both Tca8113 and KB cell lines. Furthermore, diverse apoptosis-associated proteins, including p53, BID, cytochrome C and caspase-3 were involved in the induction of apoptosis. Our results suggest that concurrent treatment with SAHA enhances tumor cell sensitivity to subtoxic doses of cisplatin. This may be regarded as a novel strategy for treatment of OSCC.

【免责声明】以下全部内容由[黄灿华]上传于[2011年06月07日 13时48分16秒],版权归原创者所有。本文仅代表作者本人观点,与本网站无关。本网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。

我要评论

全部评论 0

本学者其他成果

    同领域成果